| HGNC Family | Non-coding RNAs |
| Name | microRNA 383 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nResearch across multiple human malignancies indicates that miR‑383 is frequently downregulated in tumor tissues compared with their normal counterparts. In studies of testicular maturation arrest, medulloblastoma, and glioma, diminished miR‑383 levels were associated with aberrant cell proliferation, defective cell cycle regulation, and impaired apoptosis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "8"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, miR‑383 exerts its tumor‐suppressive functions by directly targeting a range of oncogenic drivers and cell‐cycle regulators. For example, in different tumor settings its actions include downregulation of transcription factors and metabolic enzymes such as IRF1, PRDX3, TRIM27, LDHA, Cyclin E2, EPAS1, and CREPT; in prostate cancer, reduction of CD44 expression by miR‑383 underlies a decrease in tumor‐initiating potential, while in hepatocellular carcinoma and non‐small cell lung cancer its targeting of key mediators like APRIL and EPAS1 has been linked to reduced proliferation and invasion."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "9", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAdditional investigations reveal that miR‑383 also modulates drug responsiveness, DNA damage repair, and cellular metabolism. In hepatocellular carcinoma, for instance, miR‑383 targeting of EIF5A2 enhances chemosensitivity, while in testicular carcinoma cells it inhibits H2AX phosphorylation via PNUTS downregulation. Beyond cancer, miR‑383 influences processes in pancreatic carcinoma, islet β‑cells, and even diabetic nephropathy. Moreover, its activity is intricately regulated through competing endogenous RNA networks involving long non‑coding RNAs such as HOXC13‑AS and PTTG3P, underscoring its emerging potential as a diagnostic, prognostic, and therapeutic target."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "J Lian, H Tian, L Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2010.70"}], "href": "https://doi.org/10.1038/cddis.2010.70"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21368870"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21368870"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kay Ka-Wai Li, Jesse Chung-Sean Pang, Kin-Mang Lau, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-383 is downregulated in medulloblastoma and targets peroxiredoxin 3 (PRDX3)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Pathol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/bpa.12014"}], "href": "https://doi.org/10.1111/bpa.12014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23227829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23227829"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zhanwen He, Danyang Cen, Xiangyang Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12032-013-0557-0"}], "href": "https://doi.org/10.1007/s12032-013-0557-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23564324"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23564324"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Helong Huang, Hui Tian, Zhengzheng Duan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-383 impairs phosphorylation of H2AX by targeting PNUTS and inducing cell cycle arrest in testicular embryonal carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2014.01.016"}], "href": "https://doi.org/10.1016/j.cellsig.2014.01.016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24462707"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24462707"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Zhou Xu, Xingruo Zeng, Daofeng Tian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2014.10.047"}], "href": "https://doi.org/10.1016/j.bbrc.2014.10.047"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25450356"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25450356"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Dawei Xu, Pengju Ma, Guojun Gao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 expression regulates proliferation, migration, invasion, and apoptosis in human glioma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-3378-2"}], "href": "https://doi.org/10.1007/s13277-015-3378-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25936342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25936342"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Xing-Hua Liao, Li Zheng, Hong-Peng He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "STAT3 regulated ATR via microRNA-383 to control DNA damage to affect apoptosis in A431 cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Signal (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cellsig.2015.08.005"}], "href": "https://doi.org/10.1016/j.cellsig.2015.08.005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26261078"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26261078"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Lin Chen, Haitao Guan, Chunyan Gu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4071-1"}], "href": "https://doi.org/10.1007/s13277-015-4071-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26385772"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26385772"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Xinyu Wang, Yanli Ren, Zhiqiong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulation of 5S rRNA by miR-150 and miR-383 enhances c-Myc-rpL11 interaction and inhibits proliferation of esophageal squamous carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.11.012"}], "href": "https://doi.org/10.1016/j.febslet.2015.11.012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26606907"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26606907"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yanhong Shang, Aimin Zang, Jinghua Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 is a tumor suppressor and potential prognostic biomarker in human non-small cell lung caner."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.08.006"}], "href": "https://doi.org/10.1016/j.biopha.2016.08.006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27551765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27551765"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Junbao Liu, Yuchang Dou, Minjia Sheng "}, {"type": "b", "children": [{"type": "t", "text": "Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2016.07.038"}], "href": "https://doi.org/10.1016/j.biopha.2016.07.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27567588"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27567588"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Hongjing Ma, Bin Liu, Shuoying Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 is a tumor suppressor in human lung cancer by targeting endothelial PAS domain-containing protein 1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biochem Funct (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbf.3237"}], "href": "https://doi.org/10.1002/cbf.3237"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27862077"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27862077"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "N Bucay, K Sekhon, T Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2016.419"}], "href": "https://doi.org/10.1038/onc.2016.419"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27893706"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27893706"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Shirin Azarbarzin, Mohammad Ali Hosseinpour Feizi, Reza Safaralizadeh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Value of MiR-383, an Intronic MiRNA, as a Diagnostic and Prognostic Biomarker in Intestinal-Type Gastric Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Genet (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10528-017-9793-x"}], "href": "https://doi.org/10.1007/s10528-017-9793-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28243881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28243881"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Guo-Jun Wei, Gang An, Zuo-Wei Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Suppression of MicroRNA-383 Enhances Therapeutic Potential of Human Bone-Marrow-Derived Mesenchymal Stem Cells in Treating Spinal Cord Injury via GDNF."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Physiol Biochem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1159/000468057"}], "href": "https://doi.org/10.1159/000468057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28365701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28365701"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yonghui Li, Qiaoyang Ning, Jinlong Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A novel epigenetic "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "AML1-ETO/THAP10/miR-383"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " mini-circuitry contributes to t(8;21) leukaemogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Mol Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/emmm.201607180"}], "href": "https://doi.org/10.15252/emmm.201607180"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28539478"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28539478"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Jian Li, Amber R Smith, Rebecca T Marquez, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 acts as a tumor suppressor in colorectal cancer by modulating CREPT/RPRD1B expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Carcinog (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mc.22866"}], "href": "https://doi.org/10.1002/mc.22866"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29938829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29938829"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Junqing Wang, Yunyun Zhou, Xiaochun Fei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-018-29271-3"}], "href": "https://doi.org/10.1038/s41598-018-29271-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30038373"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30038373"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Peiqi Wan, Xiaojv Chi, Qiang Du, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-383 promotes cholangiocarcinoma cell proliferation, migration, and invasion through targeting IRF1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.27286"}], "href": "https://doi.org/10.1002/jcb.27286"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30145803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30145803"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Chaoyong Tu, Wei Chen, Shuqian Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 inhibits doxorubicin resistance in hepatocellular carcinoma by targeting eukaryotic translation initiation factor 5A2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.14197"}], "href": "https://doi.org/10.1111/jcmm.14197"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30801960"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30801960"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Chenyu Zhu, Qun Huang, Hongyu Zhu "}, {"type": "b", "children": [{"type": "t", "text": "miR-383 Inhibited the Cell Cycle Progression of Gastric Cancer Cells via Targeting Cyclin E2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Cell Biol (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/dna.2019.4624"}], "href": "https://doi.org/10.1089/dna.2019.4624"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31170011"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31170011"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Bingyi Shao, Xiaohui Fu, Xian Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RP11-284F21.9 promotes oral squamous cell carcinoma development via the miR-383-5p/MAL2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Oral Pathol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jop.12946"}], "href": "https://doi.org/10.1111/jop.12946"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31397491"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31397491"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Jianchu Wang, Libai Lu, Zongjiang Luo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109551"}], "href": "https://doi.org/10.1016/j.biopha.2019.109551"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31648164"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31648164"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Q-L Su, H-J Zhao, C-F Song, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 suppresses pancreatic carcinoma development via inhibition of GAB1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201912_19774"}], "href": "https://doi.org/10.26355/eurrev_201912_19774"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31858540"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31858540"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Jingwei Zhang, Xia Kong, Qizhu Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biomark (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3233/CBM-190704"}], "href": "https://doi.org/10.3233/CBM-190704"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31903982"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31903982"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Yan Cheng, Na Liu, CaiFeng Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Genet Genomic Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/mgg3.1272"}], "href": "https://doi.org/10.1002/mgg3.1272"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32441881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32441881"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "WenXing Fan, XiaoLing Wen, JinFeng Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00162 participates in the pathogenesis of diabetic nephropathy via modulating the miR-383/HDAC9 signalling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Artif Cells Nanomed Biotechnol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21691401.2020.1773487"}], "href": "https://doi.org/10.1080/21691401.2020.1773487"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32677473"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32677473"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xiaoyun Cheng, Yueye Huang, Peng Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-383 ameliorates high glucose-induced β-cells apoptosis and hyperglycemia in high-fat induced diabetic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2020.118571"}], "href": "https://doi.org/10.1016/j.lfs.2020.118571"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33058915"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33058915"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Shirin Azarbarzin, Mohammad Ali Hosseinpour-Feizi, Seyed Mahdi Banan Khojasteh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2020.118939"}], "href": "https://doi.org/10.1016/j.lfs.2020.118939"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33359245"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33359245"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Shu Wang, Xianfeng Chen, Tiankui Qiao "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA MIR4435‑2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR‑383‑5p/RBM3 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2021.8050"}], "href": "https://doi.org/10.3892/or.2021.8050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33846802"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33846802"}]}]}]}
|
| Synonyms | MIRN383, HSA-MIR-383, MIR-383 |
| NCBI Gene ID | 494332 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR383 has 249 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 16 datasets.
Click the + buttons to view associations for MIR383 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR383 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR383 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR383 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR383 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR383 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR383 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR383 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR383 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR383 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR383 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MIR383 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR383 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR383 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR383 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR383 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR383 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |